Why Eli Lilly (LLY) Stock Rose 0.60% in 10 Minutes on Nov 9, 2026
The 0.60% gain was larger than any reaction MoveSurge measured after Eli Lilly headlines between Aug 11, 2026 and Nov 8, 2026; the largest of those was +0.49% in 10 minutes, on Oct 29, 2026.
- LLY rose 0.60% in the 10 minutes after the 09:40:16 ET headline, from $1,375.00 to $1,383.23.
- The headline crossed 10 minutes into the regular session.
- The move kept building after the first minute: +0.53% at one minute, +0.60% at 10 minutes.
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| LLY | 1375.00 | 1375.00 | 1382.31 | 1383.23 | +0.53% | +0.60% |
Eli Lilly (LLY) shares rose 0.60% in the 10 minutes after this headline reached the MoveSurge news feed at 09:40:16 ET on Monday, November 9, 2026: “In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity.”
LLY in the first 10 minutes
From a reference price of $1,375.00 just before the headline, the stock was up 0.53% after one minute and up 0.60%, at $1,383.23, after 10 minutes. The move kept building after the first minute. The headline crossed 10 minutes into the regular session.
Earlier LLY headlines and the measured reaction
The 0.60% gain was larger than any reaction MoveSurge measured after Eli Lilly headlines between Aug 11, 2026 and Nov 8, 2026; the largest of those was +0.49% in 10 minutes, on Oct 29, 2026.
- Nov 6, 2026, 12:49 ET: “Hims & Hers partners directly with Eli Lilly on obesity drugs” (-0.35% in 10 minutes)
- Nov 2, 2026, 14:46 ET: “Eli Lilly (LLY) options: 250 Jan 2028 $1600 calls traded at the bid for $4.63M” (+0.28% in 10 minutes)
- Oct 29, 2026, 11:40 ET: “Eli Lilly reported $303 million in asset impairment, restructuring and other special charges for the three months ended Sept. 30 in an SEC filing” (+0.36% in 10 minutes)
- Oct 29, 2026, 09:44 ET: “Walmart, Eli Lilly and three other companies opt out of OKX and ICE tokenized-stock plans, raising objections from more than 50% of the original roster” (+0.49% in 10 minutes)
Eli Lilly at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $1.29 trillion (as of Nov 9, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
What headline moved Eli Lilly stock on November 9, 2026?
At 09:40:16 ET, this headline crossed: “In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity.” The stock rose 0.60% in the next 10 minutes.
How far did LLY move after the headline?
From $1,375.00 just before the headline to $1,383.23 10 minutes later, a +0.60% move.
What else has moved LLY stock recently?
The two largest measured reactions before November 9, 2026: Oct 29, 2026, Walmart, Eli Lilly and three other companies opt out of OKX and ICE tokenized-stock plans, raising objections from more than 50% of the original roster (+0.49% in 10 minutes); Oct 29, 2026, Eli Lilly reported $303 million in asset impairment, restructuring and other special charges for the three months ended Sept. 30 in an SEC filing (+0.36% in 10 minutes).
Sources
-
LLY headline and measured reaction, Nov 9, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free